Incremental Healthcare Costs for Persons With Treatment-resistant Depression in Managed Care Organizations
Advertisement
Advertisement
Trending on AJMC
1
Medicare Part D Ruxolitinib Spending Hits $49.6 Million as Use Surges
2
Surrogate End Points, Drug Costs Complicate Oncology Formularies
3
COVID-19 or Flu? Symptoms Alone Can't Tell: Tammy Lundstrom, MD, JD
4
Perceptions About CGMs Among Primary Care Physicians and Endocrinologists
5